Generic Name: dasabuvir

Pronunciation: N/A

Abbreviation: N/A

Other Market Name: N/A

Drug Class: Non-Nucleoside NS5B Polymerase Inhibitors

Company: AbbVie

Approval Status: Approved

Generic Version Available: No

Experimental Code: ABT-333


General Info

Approved for use in Europe, Exviera is taken with Viekirax, the same combination of drugs found in Viekira Pak, which is no longer available in the United States. 


Dosage

Dosing Info: N/A


Side Effects

N/A


For More Info: http://www.viekira.com/

Co-Pay Program Info: http://www.hepmag.com/basics/hepatitis-c-basics/paying-hepatitis-c-treatment

Patient Assistance Program Info: http://www.hepmag.com/basics/hepatitis-c-basics/paying-hepatitis-c-treatment

Last Reviewed: March 5, 2019